COST-UTILITY ANALYSIS OF DONEPEZIL FOR THE TREATMENT OF ALZHEIMER'S DISEASE IN THAILAND

被引：0
|
作者：
Permsuwan, U. [1 ]
Niwatananun, W. [1 ]
Pimkrai, A. [2 ]
机构：
[1] Chiang Mai Univ, Chiang Mai 50000, Thailand
[2] Chiang Mai Neurol Hosp, Chiang Mai, Thailand
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.268
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A648 / A648
页数：1
相关论文
共 50 条
  • [31] COST-UTILITY ANALYSIS
    NICHOLLS, A
    BRITISH MEDICAL JOURNAL, 1993, 307 (6913): : 1213 - 1213
  • [32] Optimising Alzheimer's Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment
    Aye, S.
    Handels, R.
    Winblad, B.
    Jonsson, L.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (04): : 928 - 942
  • [33] ADAPTATION OF A COST-UTILITY MODEL OF RASAGILINE IN THE TREATMENT OF PARKINSON'S DISEASE IN CHINA
    Chen, S.
    Chen, H.
    Zhang, B.
    Shang, H.
    Tan, K. H.
    Ma, F.
    Dorey, J.
    Le Lay, A.
    VALUE IN HEALTH, 2018, 21 : S94 - S94
  • [34] Cost-utility model of rasagiline in the treatment of advanced Parkinson's disease in Finland
    Hudry, J
    Rinne, JO
    Keränen, T
    Eckert, L
    Cochran, JM
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (04) : 651 - 657
  • [35] Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe
    Rencz, Fanni
    Gulacsi, Laszlo
    Pentek, Marta
    Gecse, Krisztina B.
    Dignass, Axel
    Halfvarson, Jonas
    Gomollon, Fernando
    Baji, Petra
    Peyrin-Biroulet, Laurent
    Lakatos, Peter L.
    Brodszky, Valentin
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (06) : 597 - 606
  • [36] TREATMENT OF ADVANCED PARKINSON'S DISEASE IN THE UNITED STATES: A COST-UTILITY MODEL
    Tarrants, M. L.
    Groenendaal, H.
    Armand, C.
    VALUE IN HEALTH, 2009, 12 (07) : A370 - A370
  • [37] Treatment of Advanced Parkinson’s Disease in the United StatesA Cost-Utility Model
    Huybert Groenendaal
    Marcy L. Tarrants
    Christophe Armand
    Clinical Drug Investigation, 2010, 30 : 789 - 798
  • [38] Treatment of Advanced Parkinson's Disease in the United States A Cost-Utility Model
    Groenendaal, Huybert
    Tarrants, Marcy L.
    Armand, Christophe
    CLINICAL DRUG INVESTIGATION, 2010, 30 (11) : 789 - 798
  • [39] Treatment of advanced Parkinson's disease in the United States: a cost-utility model
    Tarrants, M.
    Groenendaal, H.
    Armand, C.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S135 - S136
  • [40] COST-EFFECTIVENESS OF SCREENING AND TREATMENT OF ALZHEIMER'S DISEASE WITH DONEPEZIL IN THE UNITED KINGDOM
    Getsios, D.
    Blume, S.
    Ishak, K. J.
    MacLaine, G.
    VALUE IN HEALTH, 2009, 12 (03) : A191 - A191
12345